CD4 and inflammatory bowel disease: Therefore, we conclude that the therapeutic of A. villosum on IBD probably connected with increasing the diversity of dominant bacteria, inhibiting the activity of pathogenetic microbes, maintaining the balance of intestinal microecology, promoting Treg differentiation and function, rebalancing CD4+ T cell subsets and alleviating intestinal inflammation.